Tetra Bio-Pharma and Ovensa Will Engage in a Collaboration to Tackle Brain Cancer

by NASDAQ Market News April 11, 2019

NASDAQ Market News
Click here to email author

Nabriva Therapeutics to Present Data at ECCMID Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia (CABP) and CONTEPO™ (fosfomycin for injection) to Treat Complicated Urinary Tract Infections (cUTIs)

Correction: Oncology Venture today publishes a supplement to the prospectus published April 5, 2019 – without MAR plate

Ads